Analystreport

Adamas Pharmaceuticals Inc (NASDAQ: ADMS) was given a new $45.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

Adamas Pharmaceuticals, Inc.  (ADMS) 
Last adamas pharmaceuticals, inc. earnings: 2/25 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.adamaspharma.com/investors